No Level 4 Travel Health Notices currently exist according to CDC data, as no disease outbreak meets the agency's criteria of extreme traveler risk with no effective precautions available. Recent surveillance through early June 2026 shows only lower-level alerts, including a May Level 3 notice for Ebola in the Democratic Republic of the Congo and scattered Level 2 advisories for malaria and other vector-borne illnesses, with case trends remaining geographically contained and stable under official monitoring. Dengue and polio updates from March and May stayed at Level 1 or 2 despite global activity. Market-implied odds of 77% for no issuance by year-end reflect trader assessment that current epidemiological indicators and CDC thresholds make an extreme escalation unlikely absent a rapid, unprecedented shift in transmission dynamics before December.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,848 Обс.
$71,848 Обс.
Dec 31, 2026
$71,848 Обс.
$71,848 Обс.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 Travel Health Notices currently exist according to CDC data, as no disease outbreak meets the agency's criteria of extreme traveler risk with no effective precautions available. Recent surveillance through early June 2026 shows only lower-level alerts, including a May Level 3 notice for Ebola in the Democratic Republic of the Congo and scattered Level 2 advisories for malaria and other vector-borne illnesses, with case trends remaining geographically contained and stable under official monitoring. Dengue and polio updates from March and May stayed at Level 1 or 2 despite global activity. Market-implied odds of 77% for no issuance by year-end reflect trader assessment that current epidemiological indicators and CDC thresholds make an extreme escalation unlikely absent a rapid, unprecedented shift in transmission dynamics before December.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Ринок відкрито: Jan 19, 2026, 3:15 PM ET
Обсяг
$71,848Дата завершення
Dec 31, 2026Ринок відкрито
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 Travel Health Notices currently exist according to CDC data, as no disease outbreak meets the agency's criteria of extreme traveler risk with no effective precautions available. Recent surveillance through early June 2026 shows only lower-level alerts, including a May Level 3 notice for Ebola in the Democratic Republic of the Congo and scattered Level 2 advisories for malaria and other vector-borne illnesses, with case trends remaining geographically contained and stable under official monitoring. Dengue and polio updates from March and May stayed at Level 1 or 2 despite global activity. Market-implied odds of 77% for no issuance by year-end reflect trader assessment that current epidemiological indicators and CDC thresholds make an extreme escalation unlikely absent a rapid, unprecedented shift in transmission dynamics before December.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Обсяг
$71,848Дата завершення
Dec 31, 2026Ринок відкрито
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...No Level 4 Travel Health Notices currently exist according to CDC data, as no disease outbreak meets the agency's criteria of extreme traveler risk with no effective precautions available. Recent surveillance through early June 2026 shows only lower-level alerts, including a May Level 3 notice for Ebola in the Democratic Republic of the Congo and scattered Level 2 advisories for malaria and other vector-borne illnesses, with case trends remaining geographically contained and stable under official monitoring. Dengue and polio updates from March and May stayed at Level 1 or 2 despite global activity. Market-implied odds of 77% for no issuance by year-end reflect trader assessment that current epidemiological indicators and CDC thresholds make an extreme escalation unlikely absent a rapid, unprecedented shift in transmission dynamics before December.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання